Innovative Technology ARTIDIS has developed a proprietary nanotechnology platform for tissue analysis that can be applied in diagnostic, drug discovery, and tissue engineering settings, representing a cutting-edge solution for pathology and personalized medicine markets.
Clinical Trial Leadership The company is actively engaged in multiple multicenter clinical trials, including the ANGEL study for breast cancer, indicating strong validation and potential for adoption within oncology and diagnostic laboratories.
Strategic Partnerships ARTIDIS collaborates with prominent institutions like Hospital Clínic de Barcelona and the University of Barcelona, providing opportunities to expand into hospital networks and research centers seeking innovative diagnostic tools.
Leadership Expansion Recent appointment of CEO Julie Gerberding and board members like Ajit Singh highlights an aggressive push toward commercialization and strategic growth within the healthcare and biotech sectors.
Funding and Growth With $27M in funding and a revenue range of $1M-$10M, ARTIDIS is positioned to scale its platform, making it attractive for investors and partners looking to enter the high-potential molecular diagnostics and personalized treatment markets.
ARTIDIS uses 8 technology products and services including Open Graph, oEmbed, Shopify, and more. Explore ARTIDIS's tech stack below.
| ARTIDIS Email Formats | Percentage |
| First.Last@artidis.com | 92% |
| FirstLast@artidis.com | 3% |
| FirstLas@artidis.com | 3% |
| FLast@artidis.com | 2% |
Medical Equipment ManufacturingBasel-Town, Switzerland51-200 Employees
ARTIDIS AG is a clinical stage medical technology company developing the first nanotechnology platform for tissue analysis combined with a digital data platform, intended for broad use in drug discovery, tissue engineering as well as for rapid diagnostics and personalized treatment optimization.
Company Overview
Media & News
Funding & FinancialsARTIDIS has raised a total of $27M of funding over 3 rounds. Their latest funding round was raised on May 31, 2023 in the amount of $27M.
ARTIDIS's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsARTIDIS has raised a total of $27M of funding over 3 rounds. Their latest funding round was raised on May 31, 2023 in the amount of $27M.
ARTIDIS's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com